| Literature DB >> 31069156 |
Tatsuo Matsuda1,2,3, Eisaku Miyauchi1, Yu-Wen Hsu1,4, Satoshi Nagayama5, Kazuma Kiyotani6, Makda Zewde1, Jae-Hyun Park1, Taigo Kato1, Makiko Harada1, Shimpei Matsui5, Masashi Ueno5, Kazumasa Fukuda2, Nobuaki Suzuki7, Shoichi Hazama7, Hiroaki Nagano7, Hiroya Takeuchi2,8, Wickii T Vigneswaran9, Yuko Kitagawa2, Yusuke Nakamura1,6.
Abstract
Tumor draining lymph nodes (TDLNs) are located in the routes of lymphatic drainage from a primary tumor and have the highest risk of metastasis in various types of solid tumors. TDLNs are also considered as a tissue to activate the antitumor immunity, where antigen-specific effector T cells are generated. However, T cell receptor (TCR) repertoires in TDLNs have not been well characterized. We collected 23 colorectal cancer tumors with 203 lymph nodes with/without metastatic cancer cells (67 were metastasis-positive and the remaining 136 were metastasis-negative) and performed TCR sequencing. Metastasis-positive TDLNs showed a significantly lower TCR diversity and shared TCR clonotypes more frequently with primary tumor tissues compared to metastasis-negative TDLNs. Principal component analysis indicated that TDLNs with metastasis showed similar TCR repertoires. These findings suggest that cancer-reactive T cell clones could be enriched in the metastasis-positive TDLNs.Entities:
Keywords: T cell receptor; colorectal cancer; immunogenomics; immunotherapy; lymph node
Year: 2019 PMID: 31069156 PMCID: PMC6492974 DOI: 10.1080/2162402X.2019.1588085
Source DB: PubMed Journal: Oncoimmunology ISSN: 2162-4011 Impact factor: 8.110